SLU-PP-322
SLU-PP-322
$ 92
A synthetic small-molecule agonist of the estrogen-related receptor (ERR) family. Acts as a pharmacological exercise mimetic — it activates the same gene-expression pathways as aerobic exercise in mitochondria and muscle, without actually exercising.
Benefits
✓ Mimics effects of endurance exercise at molecular level
✓ Boosts mitochondrial biogenesis
✓ Enhances fat oxidation and metabolic rate
✓ Improved endurance capacity in animal models
✓ Potential treatment for metabolic syndrome
✓ Boosts mitochondrial biogenesis
✓ Enhances fat oxidation and metabolic rate
✓ Improved endurance capacity in animal models
✓ Potential treatment for metabolic syndrome
Side Effects
• Mild injection site irritation
• Fatigue
• Headache
• Long-term human safety not yet established research use only.
• Research still in early stages research use only.
• Fatigue
• Headache
• Long-term human safety not yet established research use only.
• Research still in early stages research use only.
Half Life
Unknown (research phase)
Note
FOR LABORATORY / RESEARCH USE ONLY. Not for human use or consumption. Not for animal or veterinary use or testing. Not a drug, food, cosmetic, or medical device, and not evaluated or approved by the FDA.
SLU-PP-322
$ 92
A synthetic small-molecule agonist of the estrogen-related receptor (ERR) family. Acts as a pharmacological exercise mimetic — it activates the same gene-expression pathways as aerobic exercise in mitochondria and muscle, without actually exercising.
FOR LABORATORY / RESEARCH USE ONLY. Not for human use or consumption. Not for animal or veterinary use or testing. Not a drug, food, cosmetic, or medical device, and not evaluated or approved by the FDA.
✓ Mimics effects of endurance exercise at molecular level
✓ Boosts mitochondrial biogenesis
✓ Enhances fat oxidation and metabolic rate
✓ Improved endurance capacity in animal models
✓ Potential treatment for metabolic syndrome
✓ Boosts mitochondrial biogenesis
✓ Enhances fat oxidation and metabolic rate
✓ Improved endurance capacity in animal models
✓ Potential treatment for metabolic syndrome
Unknown (research phase)
